199 related articles for article (PubMed ID: 30419071)
41. Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.
Storti-Melo LM; Souza-Neiras WC; Cassiano GC; Taveira LC; Cordeiro AJ; Couto VS; Póvoa MM; Cunha MG; Echeverry DM; Rossit AR; Arévalo-Herrera M; Herrera S; Machado RL
Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):58-63. PubMed ID: 21292879
[TBL] [Abstract][Full Text] [Related]
42. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP1
Priest JW; Plucinski MM; Huber CS; Rogier E; Mao B; Gregory CJ; Candrinho B; Colborn J; Barnwell JW
Malar J; 2018 Nov; 17(1):417. PubMed ID: 30413163
[TBL] [Abstract][Full Text] [Related]
43. Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas.
Kerkhof K; Canier L; Kim S; Heng S; Sochantha T; Sovannaroth S; Vigan-Womas I; Coosemans M; Sluydts V; Ménard D; Durnez L
Malar J; 2015 Sep; 14():338. PubMed ID: 26337785
[TBL] [Abstract][Full Text] [Related]
44. Low-level Plasmodium vivax exposure, maternal antibodies, and anemia in early childhood: Population-based birth cohort study in Amazonian Brazil.
Pincelli A; Cardoso MA; Malta MB; Johansen IC; Corder RM; Nicolete VC; Soares IS; Castro MC; Ferreira MU;
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009568. PubMed ID: 34264946
[TBL] [Abstract][Full Text] [Related]
45. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.
Lima-Junior JC; Tran TM; Meyer EV; Singh B; De-Simone SG; Santos F; Daniel-Ribeiro CT; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2008 Dec; 26(51):6645-54. PubMed ID: 18832003
[TBL] [Abstract][Full Text] [Related]
46. Antibody response to a new member of the DBL family (EBP2) after a brief Plasmodium vivax exposure.
Lima BAS; Fernandes GM; Torres LM; Pires CV; Alves JRS; Moreira-Nascimento SL; Nascimento MFA; Afonso SL; Costa HL; Cerávolo IP; Sousa TN; Soares IS; Ntumngia FB; Adams JH; Carvalho LH; Kano FS
PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010493. PubMed ID: 35714097
[TBL] [Abstract][Full Text] [Related]
47. Declining malaria transmission in rural Amazon: changing epidemiology and challenges to achieve elimination.
Vitor-Silva S; Siqueira AM; de Souza Sampaio V; Guinovart C; Reyes-Lecca RC; de Melo GC; Monteiro WM; Del Portillo HA; Alonso P; Bassat Q; Lacerda MV
Malar J; 2016 May; 15(1):266. PubMed ID: 27165432
[TBL] [Abstract][Full Text] [Related]
48. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil.
Cerutti C; Boulos M; Coutinho AF; Hatab Mdo C; Falqueto A; Rezende HR; Duarte AM; Collins W; Malafronte RS
Malar J; 2007 Mar; 6():33. PubMed ID: 17371598
[TBL] [Abstract][Full Text] [Related]
49. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
[TBL] [Abstract][Full Text] [Related]
50. Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivax.
Rosado J; Carrasco-Escobar G; Nolasco O; Garro K; Rodriguez-Ferruci H; Guzman-Guzman M; Llanos-Cuentas A; Vinetz JM; Nekkab N; White MT; Mueller I; Gamboa D
PLoS Negl Trop Dis; 2022 May; 16(5):e0010415. PubMed ID: 35533146
[TBL] [Abstract][Full Text] [Related]
51. Hotspots of Malaria Transmission in the Peruvian Amazon: Rapid Assessment through a Parasitological and Serological Survey.
Rosas-Aguirre A; Speybroeck N; Llanos-Cuentas A; Rosanas-Urgell A; Carrasco-Escobar G; Rodriguez H; Gamboa D; Contreras-Mancilla J; Alava F; Soares IS; Remarque E; D Alessandro U; Erhart A
PLoS One; 2015; 10(9):e0137458. PubMed ID: 26356311
[TBL] [Abstract][Full Text] [Related]
52. Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon.
Bharti AR; Chuquiyauri R; Brouwer KC; Stancil J; Lin J; Llanos-Cuentas A; Vinetz JM
Am J Trop Med Hyg; 2006 Oct; 75(4):610-6. PubMed ID: 17038681
[TBL] [Abstract][Full Text] [Related]
53. Influence of HLA-DRB-1 alleles on the production of antibody against CSP, MSP-1, AMA-1, and DBP in Brazilian individuals naturally infected with Plasmodium vivax.
Storti-Melo LM; da Costa DR; Souza-Neiras WC; Cassiano GC; Couto VS; Póvoa MM; Soares Ida S; de Carvalho LH; Arevalo-Herrera M; Herrera S; Rossit AR; Cordeiro JA; de Mattos LC; Machado RL
Acta Trop; 2012 Feb; 121(2):152-5. PubMed ID: 22107686
[TBL] [Abstract][Full Text] [Related]
54. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
55. Micro-heterogeneity of malaria transmission in the Peruvian Amazon: a baseline assessment underlying a population-based cohort study.
Rosas-Aguirre A; Guzman-Guzman M; Gamboa D; Chuquiyauri R; Ramirez R; Manrique P; Carrasco-Escobar G; Puemape C; Llanos-Cuentas A; Vinetz JM
Malar J; 2017 Aug; 16(1):312. PubMed ID: 28778210
[TBL] [Abstract][Full Text] [Related]
56. Humoral immune responses against the malaria vaccine candidate antigen Plasmodium vivax AMA-1 and IL-4 gene polymorphisms in individuals living in an endemic area of the Brazilian Amazon.
Tomaz FM; da Cruz Furini AA; Capobianco MP; Póvoa MM; Trindade PC; Fraga VD; Conceição LM; de Azevedo LR; Oliani SM; Cassiano GC; Cavasini CE; Dos Santos SE; Machado RL
Cytokine; 2015 Aug; 74(2):273-8. PubMed ID: 25922277
[TBL] [Abstract][Full Text] [Related]
57. Unexpected high circulation of Plasmodium vivax in asymptomatic children from Kédougou, southeastern Senegal.
Niang M; Diop F; Niang O; Sadio BD; Sow A; Faye O; Diallo M; Sall AA; Perraut R; Toure-Balde A
Malar J; 2017 Dec; 16(1):497. PubMed ID: 29284488
[TBL] [Abstract][Full Text] [Related]
58. Identification and Immunological Characterization of the Ligand Domain of Plasmodium vivax Reticulocyte Binding Protein 1a.
Ntumngia FB; Thomson-Luque R; Galusic S; Frato G; Frischmann S; Peabody DS; Chackerian B; Ferreira MU; King CL; Adams JH
J Infect Dis; 2018 Aug; 218(7):1110-1118. PubMed ID: 29741629
[TBL] [Abstract][Full Text] [Related]
59. Soluble recombinant merozoite surface antigen-142kDa of Plasmodium vivax: An improved diagnostic antigen for vivax malaria.
Mirahmadi H; Fallahi S; Seyyed Tabaei SJ
J Microbiol Methods; 2016 Apr; 123():44-50. PubMed ID: 26851675
[TBL] [Abstract][Full Text] [Related]
60. Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence.
Baum E; Sattabongkot J; Sirichaisinthop J; Kiattibutr K; Davies DH; Jain A; Lo E; Lee MC; Randall AZ; Molina DM; Liang X; Cui L; Felgner PL; Yan G
Malar J; 2015 Feb; 14():95. PubMed ID: 25849211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
